TNKASE (tenecteplase) - Roche, Boehringer Ingelheim
A Patient with Complete Post-Operative Vision Loss Following Transcatheter Aortic Valve Replacement Successfully Treated with Tenecteplase (AHA 2026) - Sep 5, 2026 - Abstract #Sa2028; Pres time: Nov 7, 2026; 10:30 AM - 11:30 AM; Location: Clinical Science Zone 2‚ Science and Technology Hall‚ South Hall‚ Leve; In-Person; Board no. 2028; No abstract available 
Clinical • Cardiovascular
https://eppro01.ativ.me/web/page.php?page=session&project=AHA26&id=P10058
 
Suzanne Baron; Nupur Goel; Barbara Voetsch
 
Sep 5, 2026
 
Prev Next